文献速递心外重症与机械循环支持

连续流左心室辅助装置患者的主动脉瓣反流:当代综述

Aortic regurgitation in patients with a left ventricular assist device: A contemporary review.
PubMed 文献 · J Heart Lung Transplant · 2018-09-07

本文综述连续流左心室辅助装置(CF-LVAD)患者主动脉瓣反流(AR)的发生机制、危险因素及超声评估方法。AR在植入后第一年影响25%至30%的患者,是症状性心衰复发的常见原因,但预后独立影响及最佳诊疗尚无定论。

要点

  • CF-LVAD植入后第一年25%至30%患者发生AR,可致心衰复发。
  • 危险因素包括高龄、低体表面积、高血压、主动脉根部大、瓣膜永久关闭等。
  • 本文提供结构化超声心动图方法以准确评估瓣膜功能障碍。

核心结论

  • CF-LVAD患者AR发生率高且与症状性心衰复发相关,但预后独立影响及最佳诊疗尚无明确推荐。

研究设计与样本

  • 本文为叙述性综述,检索并汇总CF-LVAD患者主动脉瓣反流相关文献,未报告系统检索范围或样本量。

主要发现

  • CF-LVAD植入后第一年25%至30%患者发生AR。
  • AR机制多因素,包括瓣叶改变、根部生物力学改变及左室过度卸负荷,促进瓣叶重塑与交界融合。
  • 已知危险因素包括高龄、低体表面积、系统性高血压、主动脉根部直径大、主动脉瓣永久关闭及支持持续时间。
  • 流出道人工血管与升主动脉吻合角度变异可诱导主动脉壁结构改变,促进瓣膜病进展。

关键数值与推荐

  • 本文提供结构化超声心动图方法用于评估CF-LVAD患者主动脉瓣功能障碍,未报告具体诊断阈值。

临床怎么用

  • 临床应关注CF-LVAD患者AR危险因素,并采用结构化超声心动图评估主动脉瓣功能。
  • AR对预后独立影响存争议,治疗决策需个体化,尚无明确指南推荐。

局限性

  • AR对LVAD患者预后的独立影响尚存争议。
  • 最佳诊断标准与治疗尚无明确推荐。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aortic regurgitation (AR) developing while using a continuous-flow left ventricular assist device (CF-LVAD) affects 25% to 30% of patients within the first year of implantation and is increasingly being recognized as a cause of recurrence of symptomatic heart failure (HF). The underlying mechanisms are likely multifactorial, including changes in the leaflets of the aortic valve (AV), altered root biomechanics, and excessive left ventricular (LV) unloading, together promoting cusp remodeling and commissural fusion. Known risk factors for the development of AR while under support include advanced age, lower body surface area, systemic hypertension, large aortic root diameter, permanently closed AV, and duration of support. Further, variants in the anastomotic angle between the outflow graft and the ascending aorta have recently been recognized to induce structural changes in the aortic wall, contributing to the development and progression of AV disease. Nevertheless, it remains controversial as to whether AR on LVAD has an independent impact on prognosis, and no clear recommendation exists regarding its optimal diagnosis criteria and treatment. Herein we briefly review the literature and focus on the latest results regarding development of AR in patients supported with CF-LVADs. We also provide a structured echocardiographic approach for an accurate assessment of AV dysfunction in this challenging situation.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Bouabdallaoui N, El-Hamamsy I, Pham M, et al. Aortic regurgitation in patients with a left ventricular assist device: A contemporary review. J Heart Lung Transplant. 2018. PMID: 30197211. doi:10.1016/j.healun.2018.07.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。